Skip to main content
Premium Trial:

Request an Annual Quote

NIH Grants will Support Early-Stage Science

NEW YORK (GenomeWeb News) – Under a grant program focused on early-stage ideas and technologies, the National Institutes of Health will give up to $275,000 over a two-year period to researchers seeking funding for potentially risky but rewarding studies.

The Exploratory/Developmental Grant Program will fund research through the National Human Genome Research Institute and other institutes that "may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research," NIH said in a request for applications.

These grants are specifically meant to encourage new research projects that are in the beginning or discovery phases of development.

Applicants for the funds may seek no more than $200,000 in funding per year.

Filed under

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.